Literature DB >> 25747777

In silico analysis of binding of neurotoxic venom ligands with acetylcholinesterase for therapeutic use in treatment of Alzheimer's disease.

Maleeha Waqar1, Sidra Batool2.   

Abstract

Acetylcholinesterases (AChE) are enzymes that function in hydrolyzing the neurotransmitter acetylcholine. Diminished levels of acetylcholine have been reported for various neurodegenerative diseases, especially Alzheimer's. Therefore, acetylcholinesterase inhibitors are being considered quite effective in treating these diseases. Fasciculin 2 is a toxin isolated from Eastern green mamba that had been reported as a reversible acetylcholinesterase inhibitor. In this study, we have reported the in silico analysis of venom toxins via various computational tools used for drug designing, to find out the protein-protein interaction of these toxins in complex with acetylcholinesterase enzyme. In total 15 toxins have been selected from the venoms of various species as ligand dataset, to study their binding interactions with the acetylcholinesterase enzyme.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Acetylcholine; Acetylcholinesterases; Alzheimer’s; Eastern green mamba; Fasciculin 2; In silico; Neurodegenerative diseases; Neurotransmitter; Venom

Mesh:

Substances:

Year:  2015        PMID: 25747777     DOI: 10.1016/j.jtbi.2015.02.028

Source DB:  PubMed          Journal:  J Theor Biol        ISSN: 0022-5193            Impact factor:   2.691


  6 in total

1.  In silico analysis of binding interaction of conantokins with NMDA receptors for potential therapeutic use in Alzheimer's disease.

Authors:  Maleeha Waqar; Sidra Batool
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2017-09-20

Review 2.  Animal Toxins as Therapeutic Tools to Treat Neurodegenerative Diseases.

Authors:  Jessica M de Souza; Bruno D C Goncalves; Marcus V Gomez; Luciene B Vieira; Fabiola M Ribeiro
Journal:  Front Pharmacol       Date:  2018-02-23       Impact factor: 5.810

Review 3.  Natural Peptides in Drug Discovery Targeting Acetylcholinesterase.

Authors:  Vivitri Prasasty; Muhammad Radifar; Enade Istyastono
Journal:  Molecules       Date:  2018-09-13       Impact factor: 4.411

4.  Fucoxanthin's Optimization from Undaria pinnatifida Using Conventional Heat Extraction, Bioactivity Assays and In Silico Studies.

Authors:  Catarina Lourenço-Lopes; Maria Fraga-Corral; Anton Soria-Lopez; Bernabe Nuñes-Estevez; Marta Barral-Martinez; Aurora Silva; Ningyang Li; Chao Liu; Jesus Simal-Gandara; Miguel A Prieto
Journal:  Antioxidants (Basel)       Date:  2022-06-29

5.  Cannabis Constituents and Acetylcholinesterase Interaction: Molecular Docking, In Vitro Studies and Association with CNR1 rs806368 and ACHE rs17228602.

Authors:  Tiyyaba Furqan; Sidra Batool; Rabia Habib; Mamoona Shah; Huba Kalasz; Ferenc Darvas; Kamil Kuca; Eugenie Nepovimova; Sajida Batool; Syed M Nurulain
Journal:  Biomolecules       Date:  2020-05-13

6.  Neuroactive venom compounds obtained from Phlogiellus bundokalbo as potential leads for neurodegenerative diseases: insights on their acetylcholinesterase and beta-secretase inhibitory activities in vitro.

Authors:  Simon Miguel M Lopez; Jeremey S Aguilar; Jerene Bashia B Fernandez; Angelic Gayle J Lao; Mitzi Rain R Estrella; Mark Kevin P Devanadera; Cydee Marie V Ramones; Aaron Joseph L Villaraza; Leonardo A Guevarra; Myla R Santiago-Bautista; Librado A Santiago
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2021-06-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.